Sonidegib - Latest Advances

A case of basal cell nevus syndrome with a SUFU mutation.

Journal: Dermatology online journal

Published: August 28, 2025

A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report.

Journal: Clinical, cosmetic and investigational dermatology

Published: August 02, 2025

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

Journal: Dermatology online journal

Published: July 24, 2025

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Journal: JAMA dermatology

Published: July 16, 2025

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Journal: The Australasian journal of dermatology

Published: June 27, 2025

Rapid and Modular Access to All-Carbon Quaternary Center-Containing 2,2-Disubstituted Bicyclo[1.1.1]pentanes via Cyanocarbene Addition to Bicyclo[1.1.0]butanes.

Journal: Angewandte Chemie (International ed. in English)

Published: June 24, 2025

Real-world safety profile of sonidegib: a disproportionality analysis based on the FDA adverse event reporting system.

Journal: Frontiers in oncology

Published: June 07, 2025

Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus.

Journal: International journal of dermatology

Published: June 04, 2025

Sonic Hedgehog signaling in spinal cord injury: mechanisms and therapeutic implications.

Journal: Frontiers in molecular neuroscience

Published: May 07, 2025

Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel.

Journal: Journal of drugs in dermatology : JDD

Published: May 06, 2025

Current treatment options for locally advanced and metastatic basal cell carcinoma. A narrative review.

Journal: Expert review of anticancer therapy

Published: April 29, 2025

Postauthorization safety study (NISSO) assessing the long-term safety profile of sonidegib in patients with locally advanced basal cell carcinoma: interim analysis from the Spanish cohort.

Journal: Actas dermo-sifiliograficas

Published: April 23, 2025

Filters

A case of basal cell nevus syndrome with a SUFU mutation.

A case of basal cell nevus syndrome with a SUFU mutation.

A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report.

A Sonidegib Experience in the Treatment of Basal Cell Carcinoma with Systemic Lupus Erythematosus: A Case Report.

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

A review of the safety, efficacy, and administration of hedgehog inhibitors for the treatment of advanced basal cell carcinoma: an expert consensus panel.

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Quantifying the Role of Specialty Medications in Medicare Part D Expenditures in Dermatology.

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Multicenter Retrospective Case Series on the Real-World Experience With Sonidegib for the Management of Gorlin Syndrome.

Rapid and Modular Access to All-Carbon Quaternary Center-Containing 2,2-Disubstituted Bicyclo[1.1.1]pentanes via Cyanocarbene Addition to Bicyclo[1.1.0]butanes.

Rapid and Modular Access to All-Carbon Quaternary Center-Containing 2,2-Disubstituted Bicyclo[1.1.1]pentanes via Cyanocarbene Addition to Bicyclo[1.1.0]butanes.

Real-world safety profile of sonidegib: a disproportionality analysis based on the FDA adverse event reporting system.

Real-world safety profile of sonidegib: a disproportionality analysis based on the FDA adverse event reporting system.

Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus.

Evaluation of Sonidegib Cytoreductive Activity in Locally Advanced Basal Cell Carcinoma Treatment: A Delphi Consensus.

Sonic Hedgehog signaling in spinal cord injury: mechanisms and therapeutic implications.

Sonic Hedgehog signaling in spinal cord injury: mechanisms and therapeutic implications.

Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel.

Efficacy and Safety of Hedgehog Inhibitors for Advanced Basal Cell Carcinoma: An Expert Consensus Panel.

Current treatment options for locally advanced and metastatic basal cell carcinoma. A narrative review.

Current treatment options for locally advanced and metastatic basal cell carcinoma. A narrative review.

Postauthorization safety study (NISSO) assessing the long-term safety profile of sonidegib in patients with locally advanced basal cell carcinoma: interim analysis from the Spanish cohort.

Postauthorization safety study (NISSO) assessing the long-term safety profile of sonidegib in patients with locally advanced basal cell carcinoma: interim analysis from the Spanish cohort.